✦ LIBER ✦

Significance and correlations of molecular analysis results in patients with philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia

✍ Scribed by Hagop M. Kantarjian; Mordechai Shtalrid; Razelle Kurzrock; Marc Buck; Willard T. Dalton; Ann Lemaistre; Sanford A. Stass; Kenneth B. McCredie; Jordan Gutterman; Emil J. Freireich; Moshe Talpaz

Book ID: 117014914
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 850 KB
Volume: 85
Category: Article
ISSN: 1555-7162
DOI: 10.1016/s0002-9343(88)80235-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular and clinical investigations in

Molecular and clinical investigations in Philadelphia chromosome-negative chronic myelogenous leukemia

✍ Junko H. Ohyashiki; Kazuma Ohyashiki; Hisao Ito; Keisuke Toyama 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 426 KB

Characteristics and outcome of patients

Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia

✍ Francesco Onida; Greg Ball; Hagop M. Kantarjian; Terry L. Smith; Armand Glassman 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

## Abstract ## BACKGROUND Up to 5% of patients with chronic myelogenous leukemia (CML) do not have the Philadelphia (Ph) translocation t(9;22)(q34;q11) or a __bcr__/__abl__ molecular rearrangement. Although the diagnostic criteria of this entity are still under debate, there is general agreement t

Evolution of karyotypes in philadelphia

Evolution of karyotypes in philadelphia (Ph1) chromosome-negative chronic myelogenous leukemia

✍ Uri Mintz; James Vardiman; Harvey M. Golomb; Janet D. Rowley 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB 👁 2 views

Chromosomal abnormalities in Philadelphi

Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase

✍ Jorge Medina; Hagop Kantarjian; Moshe Talpaz; Susan O'Brien; Guillermo Garcia-Ma 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract ## BACKGROUND Anecdotal cases of chromosomal abnormalities in Philadelphia chromosome (Ph)‐negative metaphases have been reported in patients with chronic myelogenous leukemia (CML) in the chronic phase during treatment with interferon and, more recently, with imatinib. This phenomenon

The breakpoint cluster region site in pa

The breakpoint cluster region site in patients with Philadelphia chromosome–positive chronic myelogenous leukemia. Clinical, laboratory, and prognostic correlations

✍ Claire F. Verschraegen; Hagop M. Kantarjian; Cherryl Hirsch-Ginsberg; Ming S. Le 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 608 KB

Philadelphia chromosome-negative chronic

Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long term follow-up results

✍ Jorge E. Cortes; Moshe Talpaz; Miloslav Beran; Susan M. O'Brien; Mary B. Rios; S 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

Background. Five to 10% of patients with chronic myelogenous leukemia (CML) do not have the Philadelphia chromosome (Ph), but one-third of them have rearrangements of the breakpoint cluster region (BCR-positive). Methods. The authors analyzed the characteristics, treatment response, and prognosis o